A new study suggests that many Americans who qualify for blood pressure-lowering medication are still not taking it, despite the well-known role these drugs can play in preventing life-threatening complications. The findings point to a large treatment gap in the United States among adults who are considered eligible for hypertension care.
According to the report, an international group of researchers analyzed nationally representative U.S. data to estimate how many people could benefit from medication but remain untreated. Their conclusion adds to concerns that high blood pressure continues to be underdiagnosed, undertreated, or both, even though effective medicines are widely available.
The issue matters because untreated hypertension can raise the risk of major cardiovascular problems and other serious health outcomes. Blood pressure drugs are a standard part of care for many patients, and the new research highlights how many people may be missing a treatment that could improve or extend their lives.
While the trimmed report does not detail all of the reasons behind the shortfall, the findings underline an ongoing public health challenge: getting eligible patients identified and connected to treatment. The study adds fresh evidence that access, awareness, and follow-through in hypertension care remain major issues for millions of U.S. adults.
